ACADIA Pharmaceuticals Inc (ACAD) — Capital Reinvestment Ratio
ACADIA Pharmaceuticals Inc (ACAD) has a Capital Reinvestment Ratio of 0.15x as of March 2026, meaning it reinvests 0% of its operating cash flow ($33.98 Million) in capital expenditures ($5.21 Million). See debt-free asset ratio of ACADIA Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ACADIA Pharmaceuticals Inc Capital Reinvestment Ratio (2023–2025)
This chart tracks ACADIA Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Check total reinvestment intensity of ACADIA Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year Capital Reinvestment Ratio for ACADIA Pharmaceuticals Inc from 2023 to 2025. For live market cap and broader valuation context, see how much is ACADIA Pharmaceuticals Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $109.84 Million | $4.69 Million | ▲ +1187.7% |
| 2024 | 0.00x | $157.72 Million | $523.00K | ▼ -99.9% |
| 2023 | 2.40x | $16.70 Million | $40.05 Million | — |